Leaflet HYPERBIS 1mg tablets

Indicated for: hypertension

Route of administration: oral

Substance: rilmenidine (antihypertensive)

ATC: C02AC06 (Cardiovascular system | Antiadrenergic agents, centrally acting | Imidazoline receptor agonists)

Rilmenidine is a medication used for the treatment of high blood pressure. It works by stimulating imidazoline receptors in the central nervous system, reducing sympathetic activity and lowering blood pressure.

The medication is taken orally, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor blood pressure.

Patients should be aware of potential side effects, such as fatigue, dry mouth, or dizziness. It is important to inform the doctor of any unusual symptoms.

Common side effects include fatigue, dry mouth, and dizziness. In rare cases, severe reactions such as bradycardia or severe hypotension may occur. Patients should be informed of these risks before starting treatment.

General data about HYPERBIS 1mg

  • Substance: rilmenidine
  • Date of latest medicines list: 01-12-2020
  • Product code: W67019001
  • Concentration: 1mg
  • Pharmaceutical form: tablets
  • Quantity: 30
  • Product type: Original
  • Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

  • Manufacturer: LES LABORATOIRES SERVIER INDUSTRIE - FRANTA
  • Holder: ANPHARM PRZEDSIEBIORSTWO FARMACEUTYCZNE S.A. - POLONIA
  • Number: 13006/2020/01
  • Shelf life: 2 years